Fosapretero 150 mg Injection
26,92$
20,99$
Fosapretero 150 mg injection is an effective pharmaceutical solution designed to combat nausea and vomiting, particularly in patients undergoing chemotherapy. Suitable for both adults and pediatric patients aged six months and older, this medication works synergistically with other antiemetic agents to provide comprehensive relief from chemotherapy-induced nausea. While it is generally well-tolerated, users may experience side effects such as fatigue, diarrhea, and, in some cases, neutropenia and anemia. Patients should be aware of potential adverse reactions like peripheral neuropathy and dyspepsia, as well as urinary tract infections, which may occur during treatment. It is crucial for healthcare providers to monitor patients closely to manage any emerging side effects effectively. Fosapretero serves as a vital part of supportive care in oncology, enhancing the quality of life for those receiving cancer treatments. Always consult a healthcare professional before starting this medication to ensure it aligns with your specific health needs and treatment plan.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Fosapretero 150 mg injection is primarily utilized to prevent nausea and vomiting associated with chemotherapy treatments. Patients undergoing chemotherapy often experience these symptoms due to the strong medications involved. By administering Fosapretero, healthcare providers can help improve the overall comfort and quality of life for these individuals. This supportive care is essential for enabling patients to adhere to their treatment schedules.
• In addition to chemotherapy-induced nausea, Fosapretero 150 mg injection is effective in managing nausea and vomiting resulting from certain surgical procedures. It can be administered before surgery to mitigate the risk of postoperative nausea. This preemptive approach aids in faster recovery and enhances patient satisfaction after surgical interventions. The use of Fosapretero helps ensure a smoother postoperative experience.
• Fosapretero 150 mg injection is also indicated for use in patients experiencing nausea and vomiting from radiation therapy. This treatment can often provoke significant gastrointestinal distress, impacting a patient’s willingness to continue therapy. By incorporating Fosapretero into the treatment regimen, clinicians can help patients maintain their treatment plans with less discomfort. This role is crucial in managing side effects and supporting effective cancer care.
• Furthermore, Fosapretero 150 mg injection may be employed in various other situations where nausea and vomiting are prevalent, such as in patients with specific underlying conditions or those undergoing extensive medical procedures. The versatility of Fosapretero allows it to be part of comprehensive care strategies. By addressing these symptoms effectively, healthcare professionals can enhance patient compliance and overall well-being. This makes Fosapretero a valuable option in managing complex medical cases.
Benefits
Fosapretero 150 mg Injection is a highly effective solution for nausea and vomiting often associated with chemotherapy. This product successfully prevents these distressing symptoms by inhibiting the activity of substance P, a neurotransmitter responsible for triggering the vomiting reflex. As nausea and vomiting are common side effects of chemotherapy, their impact on a patient's quality of life can be significant. However, with the help of Fosapretero 150 mg, patients can experience relief and an overall improvement in their well-being. Not only does it help patients recover more comfortably from cancer treatments such as radiotherapy or chemotherapy, but it has also been shown to be very effective in preventing nausea and vomiting following surgery (only in adults). It is important to note that Fosapretero Injection should only be administered by a healthcare professional and not by the patient themselves.
Side Effects
As with all medicines, Fosapretero Injection may cause side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. If they persist or you're concerned about them, tell your doctor.
Most Common Side Effects
• Tiredness
• Weakness
• Headache
• Heartburn
• Numbness, weakness, tingling, or pain in legs or arms
• Diarrhoea
• Indigestion
• Fever
• Redness, itching, hardness, swelling, or pain at the injection site
Common Side Effects
• Painful or frequent urination
• Trouble swallowing or breathing
• Low blood cell count
• Unusual bleeding
• Fast or weak heartbeats
• Hives
• Itching
• Rash
• Skin Sores or Peeling
• Dizziness
• Swelling
How To Use
Anti-nausea Drug Fosapretero administered intravenously (into a vein) comes as a powder and is to be mixed with liquid by a health care professional, nurse or doctor in a medical facility. It is given for 1 time on the first day of a cancer chemotherapy treatment cycle. The frequency and dosage of Fosapretero 150 mg Vial injection is decided by your health care professional or doctor. You should inform your health care, professional or doctor if you face any serious side effects.
Safety Advice
• Alcohol: Avoiding alcohol consumption is advised when taking Fosapretero 150 mg Injection to reduce the risk of liver damage. It is best to refrain from drinking alcohol while on any medication.
• Kidney: Patients with kidney disease can safely use Fosapretero 150 mg. No dose adjustment of Fosapretero 150 mg is necessary.
• Breastfeeding: Breastfeeding while on Fosapretero 150 mg Vial is not recommended as it may harm the infant. Consult your doctor to discuss the potential risks and benefits of continuing to breastfeed while taking Fosaprepitant Injection 150 mg. Your doctor can help you make an informed decision for the health of both you and your baby.
• Liver: Patients with liver disease should exercise caution when using Fosapretero 150 mg Injection. It is crucial for individuals with liver disease to closely observe their liver function while using Fosapretero 150 mg and promptly inform their physician of any abnormal symptoms or changes in liver function. Adjustments to the dosage of Fosapretero Injection may be necessary for patients with liver disease.
• Pregnancy: There is a lack of sufficient and properly conducted studies on pregnant women. The use of Fosaprepitant Injection 150 mg during pregnancy should only be considered if the potential benefits outweigh the potential risks to both the mother and the fetus.
• Driving: The usage of Fosapretero Injection can lead to symptoms like dizziness, fatigue, and impaired concentration and coordination, which can potentially compromise your driving skills. To ensure your safety, it is crucial to adhere to your doctor's guidance and take necessary precautions, such as refraining from driving or operating heavy machinery if you experience any of these side effects caused by Fosapretero 150 mg.